Literature DB >> 30280776

LncRNA H19 serves as a ceRNA and participates in non-small cell lung cancer development by regulating microRNA-107.

B Qian1, D-M Wang, X-S Gu, K Zhou, J Wu, C-Y Zhang, X-Y He.   

Abstract

OBJECTIVE: To investigate whether lncRNA H19 can regulate NF1 expression through competitive binding to microRNA-107, thereby participating in the occurrence and development of non-small cell lung cancer (NSCLC). PATIENTS AND METHODS: Expression levels of H19 and NF1 in NSCLC tissues, paracancerous tissues and NSCLC cell lines were detected by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). The binding condition of microRNA-107, H19 and NF1 was detected by dual-luciferase reporter gene assay. Corresponding lentiviruses of H19 were constructed. The regulatory effects of H19 on proliferative and migratory abilities of A549 cells were detected by cell counting kit-8 (CCK-8) and transwell assay, respectively. Rescue experiments were conducted to explore the regulatory interaction between H19 and microRNA-107 in A549 cells.
RESULTS: H19 and NF1 were highly expressed in NSCLC tissues and NSCLC cell lines (A549 and HCC823) than those of controls. Overexpressed H19 increased proliferative and migratory abilities of A549 cells. Dual-luciferase reporter gene assay demonstrated that H19 regulates NF1 expression through competitive binding to microRNA-107, thereafter participating in NSCLC development.
CONCLUSIONS: H19 is highly expressed in NSCLC, which promotes NSCLC development by regulating NF1 via competitive binding to microRNA-107.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30280776     DOI: 10.26355/eurrev_201809_15925

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  14 in total

Review 1.  Long Noncoding RNAs in Lung Cancer: From Disease Markers to Treatment Roles.

Authors:  Lin Chen; Yuxin Xie; Min Yu; Qiheng Gou
Journal:  Cancer Manag Res       Date:  2022-05-21       Impact factor: 3.602

2.  LncRNA H19 Regulates BMP2-Induced Hypertrophic Differentiation of Mesenchymal Stem Cells by Promoting Runx2 Phosphorylation.

Authors:  Guangming Dai; Haozhuo Xiao; Chen Zhao; Hong Chen; Junyi Liao; Wei Huang
Journal:  Front Cell Dev Biol       Date:  2020-07-29

Review 3.  Long Non-Coding RNA in the Pathogenesis of Cancers.

Authors:  Yujing Chi; Di Wang; Junpei Wang; Weidong Yu; Jichun Yang
Journal:  Cells       Date:  2019-09-01       Impact factor: 6.600

Review 4.  Exosomal Long Non-Coding RNAs in Lung Diseases.

Authors:  Christophe Poulet; Makon-Sébastien Njock; Catherine Moermans; Edouard Louis; Renaud Louis; Michel Malaise; Julien Guiot
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

5.  Long Intergenic Noncoding RNA 00261 Acts as a Tumor Suppressor in Non-Small Cell Lung Cancer via Regulating miR-105/FHL1 Axis.

Authors:  Zhiqiang Wang; Jiru Zhang; Bo Yang; Runsheng Li; Linfang Jin; Zhenjun Wang; Haifeng Yu; Chuanxin Liu; Yong Mao; Qingjun You
Journal:  J Cancer       Date:  2019-10-19       Impact factor: 4.207

Review 6.  Competing endogenous RNAs in lung cancer.

Authors:  Meilian Zhao; Jianguo Feng; Liling Tang
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

7.  Long intergenic non-coding RNA Linc00485 promotes lung cancer progression by modulating miR-298/c-Myc axis.

Authors:  Zhenyang Zhang; Wenwei Lin; Yuhan Lin; Mingqiang Kang; Jiafu Zhu; Zhangwei Tong; Long Wu; Jianhai Sun; Jiangbo Lin
Journal:  J Cell Mol Med       Date:  2020-11-25       Impact factor: 5.310

8.  Fibroblast‑derived exosomal microRNA‑369 potentiates migration and invasion of lung squamous cell carcinoma cells via NF1‑mediated MAPK signaling pathway.

Authors:  Liping Guo; Baoli Li; Jianjun Yang; Juan Shen; Jinshan Ji; Meijing Miao
Journal:  Int J Mol Med       Date:  2020-05-22       Impact factor: 4.101

9.  LncRNAs GACAT3 and LINC00152 regulate each other through miR-103 and are associated with clinicopathological characteristics in colorectal cancer.

Authors:  Shazhou Ye; Yicong Lu; Yuqing Ru; Xiaoyue Wu; Ming Zhao; Jiayi Chen; Mingjun Xu; Qin Huang; Yibo Wang; Shanping Shi; Shizhong Bu; Yang Xi
Journal:  J Clin Lab Anal       Date:  2020-05-27       Impact factor: 2.352

10.  Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1.

Authors:  Zhenyao Chen; Qinnan Chen; Zhixiang Cheng; Jingyao Gu; Wenyan Feng; Tianyao Lei; Jiali Huang; Jiaze Pu; Xin Chen; Zhaoxia Wang
Journal:  Cell Death Dis       Date:  2020-10-14       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.